The FDA cleared ORTHOReBIRTH USA's ReBOSSIS. ORTHOReBIRTH develops orthopedic biologics.
The Latest
The FDA approved Boston Scientific's Spectra WaveWriter Spinal Cord Stimulator System.
Darrell G. Kirch, MD, president and CEO of Association of American Medical Colleges, has plans to leave his post.
Here are the 10 most-read articles featured on Becker's Spine Review between Jan. 8 and Jan. 12.
Here are five orthopedic surgeons making headlines.
Anthony Romeo, MD, is an orthopedic surgeon and professor at Chicago-based Midwest Orthopaedics at Rush.
A study, published in The Spine Journal, examined whether anterior cervical discectomy and fusion procedures are safer in hospitals or outpatient facilities.
The FDA cleared 59 orthopedic devices in December 2017.
Johnson & Johnson CEO Alex Gorsky spoke with CNBC at the J.P. Morgan Health Care Conference discussing tax reforms and the outlook for mergers and acquisitions in the medtech space.
A new study published in Spine examines the 90-day reimbursements for primary single-level posterior lumbar fusion.